The Drug Eluting Stents Center

Filter Your Results




SWEDEPAD Trials Explore Resumption of Enrollment

May 31, 2019 -- Investigators from the SWEDEPAD 1 and 2 trials are aiming to resume recruitment of patients, having reviewed mortality data from the trials following conc…

Two-Year Data Presented From EffPac Trial of iVascular's Luminor DCB

May 23, 2019 -- iVascular announced that the 24-month EffPac trial results were presented by Professor Ulf Teichgräber, MD, at EuroPCR held May 21 -- 24 in Paris, France.…

PCR Issues Statement Supporting Continued Use of Paclitaxel-Based DCBs

May 21, 2019 -- PCR has issued a statement addressing the controversy on the use of paclitaxel drug-coated balloons (DCBs) in peripheral interventions. The statement concluded…

The SAVAL Trial

Jihad A. Mustapha, MD, FACC, FSCAI; Patrick Geraghty, MD, FACS; and Hans van Overhagen, MD, PhD, EBIR

May 2019—Details on the design and rationale behind this randomized trial studying infrapopliteal drug-eluting stent use for critical limb ischemia.

FDA Paclitaxel Safety Panel Preview

Kenneth Cavanaugh, PhD; and Misti Malone, PhD

May 2019—An interview with FDA CDRH representatives discussing the upcoming advisory panel meeting to review concerns and current data on paclitaxel-eluting device use.

Safety and Efficacy Data Presented for BD's Lutonix DCB in Below-the-Knee Arteries

May 1, 2019 -- Patrick Geraghty, MD, presented 6-month results from the Lutonix BTK trial at the 2019 Charing Cross Symposium, held April 15 -- 18 in London, United Kingdom. T…

FDA Schedules Public Meeting on Paclitaxel Use in PAD

April 22, 2019 -- The FDA announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee will convene a public meeting to discuss and make recom…

Cook Medical Provides Patient-Level Paclitaxel Data From Zilver PTX Randomized Controlled Trial

April 18, 2019 -- Cook Medical announced that patient-level data from the Zilver PTX randomized controlled trial (RCT) of the company's paclitaxel-eluting peripheral stent…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.